RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 ALN Reduces Bone Turnover in Perimenopausal Women with Low BMD
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 20
SP 10
OP 11
DO 10.1177/155989771420005
UL http://mdc.sagepub.com/content/14/20/10.abstract
AB Menopause-associated bone loss begins during perimenopause, ∼?2 years before the last menstrual period. This article presents data from the Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate on Bone Mineral Density and Bone Turnover in Perimenopausal Women With Low BMD poster [ICE/ENDO 2014. Poster LBSA-0269], first study to evaluate the efficacy of an antiresorptive agent on maintaining BMD in perimenopausal women.